ニュース

Sezzle Inc. (NASDAQ:SEZL) is one of the 20 Stocks Jim Cramer Wanted You To Sell & Immediately Get Out Of. Sezzle Inc. (NASDAQ:SEZL) is a financial technology company that operates in the Buy Now, Pay Later industry. Its shares are up by 81% over the past year and by 6.5% year-to-date. Since Cramer discussed the […]

The latest analyst work on Evolus keeps the modeled fair value steady at US$14.67 per share, even as several firms reduce their published price targets. Those cuts are tied less to a change in the core valuation inputs and more to how analysts interpret the softer preliminary 2025 net revenue outlook, the 2026 guide, and the scaled back long term narrative. As you read on, you will see how to approach this evolving setup and what to watch as the story continues to develop. Stay updated as the...

After BWX Technologies had its best day on record, Cathie Wood’s ARK Invest shed shares of the nuclear play across two of its flagship funds. The sale included 2,639 shares by the which is concentrated in so-called disruptive technology and dominated by names such as Crispr Therapeutics and Advanced Micro Devices As of Friday, ARK Innovation held 303,133 BWX shares valued at roughly $69.8 million, or 1.17% of the portfolio by weight. The second fund to sell was the ARK Autonomous Technology & Robotics ETF which shed 839 shares.

Asian equities traded in the US as American depositary receipts were sharply lower Thursday morning,

Energy stocks were lower late Wednesday afternoon, with the NYSE Energy Sector Index falling 3.3% an

Energy stocks were sharply lower Wednesday afternoon, with the NYSE Energy Sector Index falling 4.2%

OPTX reports stronger margins and lower costs, leading to a narrowed year-over-year loss per share in 2025 despite flat revenue performance.

ARK Invest purchased Tesla stock for the first time in almost a year on Monday. Tesla shares fell solidly Tuesday to a seven-month low.

Adeia, ticker NasdaqGS:ADEA, has filed a patent infringement lawsuit against DISH Network over five core media and pay TV technologies. The company alleges unauthorized use of foundational patents that sit at the center of its licensing and media technology business. Adeia has reiterated its financial guidance while pursuing this action, highlighting the role of patent enforcement in its business model. Adeia enters this dispute with recent share price momentum and a current price of...

Investing.com -- A sudden leadership change at the Department of Justice (DOJ) could provide a strategic opening for Senate Republicans to derail the ongoing investigation into Federal Reserve Chair Jerome Powell, according to a public policy analysis from Barclays.

NASA's Artemis crew is almost halfway to the Moon for the 10-day mission. Space stocks forge bases after weekly rallies.

Style Box ETF report for IWD

Retail brokers could see reduced engagements and lower organic growth amid the economic fallout from

Asian equities traded in the US as American depositary receipts look set to close out the shortened

USA Rare Earth commissions Phase 1a magnet line, paving the way for NdFeB production and first deliveries in Q2 2026.

Style Box ETF report for IWF

<p>Stocks slid in March, but ETF investors kept buying. Now inflows are on pace for nearly $2 trillion this year.</p>

(Updates with Dish's response and additional information on the lawsuit in the fourth and fifth para

Adeia (ADEA) said Wednesday that its subsidiaries have filed a patent infringement lawsuit against D

Style Box ETF report for IWB

Canadian crypto miner Bitfarms (NASDAQ: $BITF) has announced plans to completely exit Bitcoin (CRYPTO: $BTC) as it ...

SELLAS Life Sciences Group Inc. (NASDAQ:SLS) is one of the popular penny stocks on Robinhood to buy. On March 17, SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) announced that it will present preclinical data on SLS009 at the American Association for Cancer Research annual meeting on April 21, 2026. SLS009, alternatively known as tambiciclib, is a […]

Fidelity Enhanced Large Cap Growth ETF (NYSEARCA:FELG) has slipped about 8% since the start of 2026, tracking closely with its benchmark as large-cap growth stocks broadly retreat. The fund gives investors exposure to the Russell 1000 Growth universe with a quantitative edge: Fidelity runs multifactor models to tilt toward companies with strong fundamentals and reasonable ... Fidelity’s ETF For Russell 1000 Large-Cap Growth

Assessing recent moves in SELLAS Life Sciences Group (SLS) SELLAS Life Sciences Group (SLS) has drawn attention after a recent run in its share price, with returns over the past 3 months and year that stand out against its mixed multi year track record. Over the past month the stock shows a gain, alongside a much stronger move in the past 3 months and a very large 1 year total return, while 5 year performance remains negative. That mix often prompts investors to revisit the story behind the...

A late-stage clinical biopharmaceutical company focused on immunotherapy for various cancers, SELLAS Life Sciences Group (NASDAQ:SLS) is at a genuinely unusual inflection point. Its shares have climbed 346% over the past year, yet the stock pulled back 13.4% in the past week to $5.04, with Q4 earnings due March 19. The reason Reddit is buzzing: ... SELLAS Stock Up 346% in a Year as Cancer Vaccine Trial Nears Its Final 8 Deaths

Telesat (TSAT.TO) on Tuesday reported net loss which narrowed in the fourth quarter, despite a lower

UBS downgrade puts Infineon’s AI and China auto exposure in focus UBS cut its rating on Infineon Technologies (XTRA:IFX) to Neutral, highlighting what it sees as limited upside in the company’s AI-related business and forecasting 7% annual declines in China auto revenue in 2026 and 2027. See our latest analysis for Infineon Technologies. Infineon’s shares have been choppy recently, with a 1 month share price return of an 8.45% decline, even as the 90 day share price return of 9.77% and 1 year...